Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

NCT04358588 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Coronavirus Infection
COVID-19
Pneumonia, Viral

Interventions

DRUG: iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System

Sponsor

Bellerophon